Microbot Medical IncNASDAQ:MBOT
- LAST PRICE1.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.0000/ 3
- Ask / Lots1.0900/ 1
- Open / Previous Close1.0000 / 1.0000
- Day Range
- 52 Week Range
- Volume27,232
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MBOT |
|---|---|---|
| 09:32 ET | 1076 | 1 |
| 09:36 ET | 100 | 1.01 |
| 09:38 ET | 300 | 1.01 |
| 09:39 ET | 100 | 1.01 |
| 09:41 ET | 124 | 1.01 |
| 09:52 ET | 447 | 1.0018 |
| 09:54 ET | 1000 | 1.0099 |
| 09:56 ET | 600 | 1.01 |
| 09:59 ET | 6576 | 1 |
| 10:30 ET | 600 | 1.0009 |
| 10:32 ET | 100 | 1.01 |
| 10:46 ET | 6100 | 1 |
| 10:50 ET | 3200 | 0.99 |
| 11:09 ET | 400 | 1 |
| 11:11 ET | 250 | 1 |
| 11:20 ET | 167 | 1 |
| 11:26 ET | 1297 | 1 |
| 12:03 ET | 183 | 1 |
| 01:12 ET | 200 | 1 |
| 03:07 ET | 200 | 1 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Microbot Medical Inc | 14.4M | -1.1x | --- |
Vicapsys Life Sciences Inc | 14.2M | -13.6x | --- |
CERo Therapeutics Holdings Inc | 14.0M | -2.4x | --- |
Edesa Biotech Inc | 13.9M | -1.8x | --- |
Inhibitor Therapeutics Inc | 15.1M | -4.8x | --- |
Akari Therapeutics PLC | 13.6M | 0.0x | --- |
Company Information
Microbot Medical Inc. is a pre-clinical medical device company. The Company is specializing in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is primarily focused on leveraging its robotic technologies with surgical robotics to improve surgical outcomes for patients. Its technological platforms include LIBERTY and NovaCross. Using its LIBERTY Endovascular Robotic Surgical System, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. It eliminates the need for capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. LIBERTY Endovascular Robotic Surgical System addresses the needs of interventional cardiology, interventional radiology and interventional neuroradiology markets.
Contact Information
- Headquarters
- 25 RECREATION PARK DR SUITE 108HINGHAM, MA, United States 02043
- Phone
- 908-938-5561
- Fax
- 302-655-5049
Executives
- Chairman of the Board, President, Chief Executive Officer
- Harel Gadot
- Chief Financial Officer
- Rachel Vaknin
- Chief Technology Officer, General Manager - Microbot Medical Ltd Israel
- Simon Sharon
- Chief Medical Officer
- Juan Diaz-Cartelle
- Independent Director
- Yoseph Bornstein
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $14.4M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 14.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.63 |
EPS | $-0.89 |
Book Value | $0.38 |
P/E Ratio | -1.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
